The sudden, unexplained removal of a research paper on private equity firms buying dermatology practices has raised questions about corporate influence.
from Health https://ift.tt/2PloFRv
November 01, 2018
Rose
Health, Health - The New York Times
No comments
Related Posts:
Coronavirus Live Updates: Pfizer Gets $1.95 Billion to Produce Vaccine by Year’s EndPresident Trump warned the outbreak would worsen and implored Americans to wear masks. Republicans are arguing over what to include in the next round of pandemic relief. from Health https://ift.tt/3fTEOaA … Read More
The Link Between Parkinson’s Disease and Toxic ChemicalsA new book calls the increasing prominence of Parkinson’s “a man-made pandemic.” from Health https://ift.tt/3fLsrNW … Read More
During Coronavirus Lockdowns, Some Doctors Wondered: Where Are the Preemies?Hospitals in several countries saw dips in premature births, which could be a starting point for future research. from Health https://ift.tt/30pgUgT … Read More
Some Vaccine Makers Say They Plan to Profit From Coronavirus VaccineModerna, which is receiving $483 million from the U.S. government, told lawmakers it would not sell its vaccine at cost. Pfizer has said it would also profit, but has so far taken no government money. from Health https://ift… Read More
Coronavirus Live Updates: Trump Says Virus Will Probably ‘Get Worse Before It Gets Better’U.S. officials accuse Chinese hackers of targeting vaccine development on behalf of the country’s intelligence service. Dr. Anthony Fauci rejected the president’s description of him as an “alarmist.” from Health https://ift.… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment